Global Biosurgery Market Size, Share, Growth Analysis, By Type(Surgical sealants, adhesives) - Industry Forecast 2023-2030

Global Biosurgery Market size was valued at USD 13.89 billion in 2021 and is poised to grow from USD 14.56 billion in 2022 to USD 24.21 billion by 2030, growing at a CAGR of 6.9% in the forecast period (2023-2030).

The global biosurgery market is undergoing significant growth and transformation, driven by advancements in surgical techniques and the rising demand for minimally invasive procedures. Biosurgery entails the use of biological products like sealants, hemostatic agents, and soft tissue repair materials to enhance healing and surgical outcomes. This growth is fueled by increasing surgical volumes, a higher prevalence of chronic illnesses, and an aging population. Furthermore, the adoption of personalized medicine and the development of innovative biologics are further boosting market expansion, despite challenges posed by strict regulatory requirements and product costs. In conclusion, the global biosurgery market offers promising opportunities for companies in the development and commercialization of advanced surgical solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the global biosurgery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

The global biosurgery market is segmented by type and region. Based on type, the market can be segmented into surgical sealants, adhesives, hemostatic agents, soft tissue patches, and bone graft substitutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers:

Increasing Demand for Minimally Invasive Surgical Procedures

The global biosurgery market is significantly propelled by the rising popularity of minimally invasive surgical techniques, which leverage biosurgery products for their advantages like reduced trauma, quicker recovery, and minimal scarring. This increasing preference among patients and surgeons for minimally invasive procedures, along with technological advancements like innovative biomaterials and surgical sealants, contributes to the market's growth.

Restraints:

Regulatory Requirements and Lengthy Approval Processes for New Products

A key obstacle confronting the global biosurgery market is the stringent regulatory prerequisites and protracted approval procedures for novel products. The regulations governing biosurgery items necessitate extensive testing, clinical trials, and adherence to safety and effectiveness criteria, resulting in substantial delays and elevated development expenses. This intricate regulatory landscape can impede manufacturers from innovating and launching new products, while the considerable expenses linked to regulatory adherence and product development may obstruct the entry of small and medium-sized enterprises into the market, creating a hurdle to market expansion.

Market Trends:

A notable trend in the global biosurgery market is the increasing adoption of minimally invasive surgical approaches, which present numerous benefits such as smaller incisions, reduced scarring, faster recovery, and fewer postoperative complications compared to traditional open surgeries. Consequently, there is a rising need for biosurgical products tailored for minimally invasive procedures, driven by the growing preference among patients and healthcare providers for less invasive treatments with comparable or superior outcomes. In response to this trend, biosurgery market manufacturers are prioritizing the development of innovative products and techniques to meet the escalating demand and improve patient satisfaction.